Explore the full directors' dealings record of HEALTHPEAK PROPERTIES, INC., a listed equity based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Operating in the Real Estate sector, HEALTHPEAK PROPERTIES, INC. has published 14 insider filings. Market capitalisation: €11.2bn. The latest transaction was disclosed on 31 January 2022 — Attribution. Among the most active insiders: GARVEY CHRISTINE. The full history is accessible without an account.
14 of 14 declarations
Healthpeak Properties, Inc. (NYSE: DOC) is a United States-listed real estate investment trust (REIT) and an S&P 500 company headquartered in Denver, Colorado. Founded in 1985, Healthpeak positions itself as an owner, operator, and developer of real estate at the intersection of healthcare discovery and delivery. For international investors, the company represents a specialized healthcare real estate platform with exposure to mission-critical properties tied to medical services, life sciences research, and senior housing. ([healthpeak.com](https://healthpeak.com/about/?utm_source=openai)) Healthpeak’s core business lines span three major property categories: life science and research campuses, outpatient medical buildings, and senior housing assets. The company’s strategy is built around owning and operating high-quality properties that serve specialized healthcare and scientific users, often in dense, supply-constrained submarkets. That focus supports recurring rental income, long-term tenant relationships, and opportunities for value creation through selective development, redevelopment, and portfolio rotation. Healthpeak describes its properties as serving the healthcare discovery and outpatient care ecosystems, reflecting a business model that is more specialized than a broad commercial REIT. ([healthpeak.com](https://healthpeak.com/about/?utm_source=openai)) Competitively, Healthpeak stands out for its institutional scale and its concentration in premium healthcare clusters. One of its most important geographic franchises is South San Francisco, where the company says its portfolio now totals 6.5 million square feet across 210 acres after recent acquisitions, reinforcing a leadership position in one of the world’s most important biotechnology submarkets. This type of clustering can support occupancy, tenant retention, and pricing power over time. In outpatient medical, Healthpeak benefits from assets located close to hospitals and healthcare systems, which tends to favor stable demand and durable utilization. ([ir.healthpeak.com](https://ir.healthpeak.com/news/news-details/2026/Healthpeak-Properties-Announces-925-Million-of-Transaction-Activity/default.aspx?utm_source=openai)) Recent developments show an active capital allocation and strategic repositioning agenda. In January 2026, Healthpeak announced roughly $925 million of transaction activity, including the acquisition of a 1.4-million-square-foot campus on Gateway Boulevard in South San Francisco for $600 million. In March 2026, the company closed a new $400 million unsecured delayed-draw term loan facility, enhancing liquidity and financial flexibility. Healthpeak also announced the formation of Janus Living, a planned pure-play, publicly traded senior housing REIT, which would allow Healthpeak to crystallize value in senior housing while sharpening its focus on outpatient medical and lab growth. Overall, on the NYSE market in the United States, Healthpeak presents itself as a focused healthcare real estate platform with a defensive profile, specialized assets, and an evolving capital strategy. ([ir.healthpeak.com](https://ir.healthpeak.com/news/news-details/2026/Healthpeak-Properties-Announces-925-Million-of-Transaction-Activity/default.aspx?utm_source=openai))